<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Malliopoulou, V</style></author><author><style face="normal" font="default" size="100%">Mourouzis, IS</style></author><author><style face="normal" font="default" size="100%">Tzeis, SM</style></author><author><style face="normal" font="default" size="100%">Cokkinos, DD</style></author><author><style face="normal" font="default" size="100%">Karamanoli, E</style></author><author><style face="normal" font="default" size="100%">Pantos, C.</style></author><author><style face="normal" font="default" size="100%">Carageorgiou, H</style></author><author><style face="normal" font="default" size="100%">Varonos, DD</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Preconditioning protects hyperthyroid hearts but attenuates HSP70 mRNA induction</style></title><secondary-title><style face="normal" font="default" size="100%">REVIEW OF CLINICAL PHARMACOLOGY AND PHARMACOKINETICS-INTERNATIONAL EDITION-</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">1999</style></year></dates><number><style face="normal" font="default" size="100%">2/3</style></number><publisher><style face="normal" font="default" size="100%">PHARMAKON-PRESS</style></publisher><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">84–84</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>